Literature DB >> 1799150

Intramedullary "holocord" oligodendroglioma: case report.

C A Pagni1, S Canavero, E Gaidolfi.   

Abstract

Primary spinal cord oligodendrogliomas are rare tumours. Only 3 holocord cases have been reported in the literature. We present a primary intramedullary "holocord" oligodendroglioma in a 13 year-old male. Scoliosis was the initial symptom. Neurological deterioration prompted MRI, which demonstrated the lesion. Total removal was achieved. This case shows that meticulous surgery may obtain an optimal result in holocord oligodendrogliomas. 2 years after surgery, the young patient has made an excellent recovery.

Entities:  

Mesh:

Year:  1991        PMID: 1799150     DOI: 10.1007/BF01402122

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  11 in total

1.  Tumors of the spinal canal in children.

Authors:  W S COXE
Journal:  Am Surg       Date:  1961-01       Impact factor: 0.688

2.  [Oligodendroglioma of spinal cord].

Authors:  L Chen
Journal:  Changgeng Yi Xue Za Zhi       Date:  1988-03-20

3.  Intraspinal tumours in children.

Authors:  C Arseni; L Horvath; D Iliescu
Journal:  Psychiatr Neurol Neurochir       Date:  1967 Mar-Apr

Review 4.  Intraspinal tumours in children (excluding dysraphism).

Authors:  M Banna; G L Gryspeerdt
Journal:  Clin Radiol       Date:  1971-01       Impact factor: 2.350

5.  Extensive oligodendrogliomas of the spinal cord with associated bone changes.

Authors:  C P O'Brien; H Z Lehrer; J C Harkin
Journal:  Neurology       Date:  1968-09       Impact factor: 9.910

6.  Surgical management of holocord intramedullary spinal cord astrocytomas in children.

Authors:  F Epstein; N Epstein
Journal:  J Neurosurg       Date:  1981-06       Impact factor: 5.115

7.  Intramedullary spinal gliomas: long-term results of surgical treatments.

Authors:  C Alvisi; M Cerisoli; M Giulioni
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

8.  Total removal of intramedullary ependymomas: follow-up study of 16 cases.

Authors:  G Fischer; L Mansuy
Journal:  Surg Neurol       Date:  1980-10

9.  Intraspinal tumors in children. A review of 81 cases.

Authors:  A L DeSousa; J E Kalsbeck; J Mealey; R L Campbell; A Hockey
Journal:  J Neurosurg       Date:  1979-10       Impact factor: 5.115

10.  Long-term results of the surgical treatment of 129 intramedullary spinal gliomas.

Authors:  B Guidetti; S Mercuri; R Vagnozzi
Journal:  J Neurosurg       Date:  1981-03       Impact factor: 5.115

View more
  6 in total

1.  Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide.

Authors:  Fulin Wang; Guangyu Qiao; Xin Lou
Journal:  J Neurooncol       Date:  2010-12-29       Impact factor: 4.130

Review 2.  Hemangioblastomas and other uncommon intramedullary tumors.

Authors:  D J Miller; I E McCutcheon
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  Primary spinal cord oligodendroglioma: case report and review of the literature.

Authors:  Kostas N Fountas; Ioannis Karampelas; Leonidas G Nikolakakos; E Christopher Troup; Joe Sam Robinson
Journal:  Childs Nerv Syst       Date:  2004-05-12       Impact factor: 1.475

4.  Surgical management of long intramedullary spinal cord tumors.

Authors:  Michael E Tobias; Matthew J McGirt; Kaisorn L Chaichana; Ira M Goldstein; Karl F Kothbauer; Fred Epstein; George I Jallo
Journal:  Childs Nerv Syst       Date:  2007-07-18       Impact factor: 1.475

5.  A very rare spinal cord tumor primary spinal oligodendroglioma: A review of sixty cases in the literature.

Authors:  Askin Esen Hasturk; Emre Cemal Gokce; Cagri Elbir; Gulce Gel; Suat Canbay
Journal:  J Craniovertebr Junction Spine       Date:  2017 Jul-Sep

Review 6.  Holocord oligodendroglioma with intracranial extension in a young adult: a case report and review of literature.

Authors:  Romulus Emmanuel H Cruz; Ranhel C De Roxas; Carmela Concepcion A Sales-Callangan; Roland Dominic G Jamora
Journal:  CNS Oncol       Date:  2018-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.